Další formáty:
BibTeX
LaTeX
RIS
@article{1659559, author = {Smejkal, Petr and Michiels, J. J. and Zapletal, Ondřej and Blatný, Jan and Batorova, A. and Pricangova, T. and Budde, U. and Hermans, C. and Mayger, K. and Moore, G. and Vangenegten, I. and Penka, Miroslav}, article_number = {3}, keywords = {Von willebrand disease; Von willebrand factor VWF antigen; VWF collagen binding; VWF ristocetine cofactor; VWF multimers; and VWF propeptide; VWF ristocetine induced platelet aggregation; Autosomal recessive; Autosomal dominant; Heredity}, language = {eng}, issn = {2689-9663}, journal = {Thrombosis & Haemostasis: Research}, title = {European Clinical, Laboratory and Molecular (2020 ECLM) Diagnostic Work-Up and Classification of Von Willebrand Disease from the Perspectives of Clinicians and Scientists}, url = {https://austinpublishinggroup.com/thrombosis-haemostasis/all-issues.php}, volume = {3}, year = {2019} }
TY - JOUR ID - 1659559 AU - Smejkal, Petr - Michiels, J. J. - Zapletal, Ondřej - Blatný, Jan - Batorova, A. - Pricangova, T. - Budde, U. - Hermans, C. - Mayger, K. - Moore, G. - Vangenegten, I. - Penka, Miroslav PY - 2019 TI - European Clinical, Laboratory and Molecular (2020 ECLM) Diagnostic Work-Up and Classification of Von Willebrand Disease from the Perspectives of Clinicians and Scientists JF - Thrombosis & Haemostasis: Research VL - 3 IS - 3 SP - 1-15 EP - 1-15 PB - Austin Publishing SN - 26899663 KW - Von willebrand disease KW - Von willebrand factor VWF antigen KW - VWF collagen binding KW - VWF ristocetine cofactor KW - VWF multimers KW - and VWF propeptide KW - VWF ristocetine induced platelet aggregation KW - Autosomal recessive KW - Autosomal dominant KW - Heredity UR - https://austinpublishinggroup.com/thrombosis-haemostasis/all-issues.php L2 - https://austinpublishinggroup.com/thrombosis-haemostasis/all-issues.php N2 - The International Society of Thrombosis Haemostasis (ISTH) classification separated Von Willebrand Disease (VWD) into type 1 and type 2 by the use of four insensitive Von Willebrand Factor (VWF) assays Ristocetine Co-factor (VWF:RCo), VWF Antigen (VWF:Ag), Ristocetine Induced Platelet Agglutination (RIPA) and VWF multimers in a low resolution gel. A complete set of VWF parameters is mandatory to discriminate between all variants of VWD type 1, 2 and 3 and includes Bleeding Time (BT), PFA-100 closure times, FVIII:C, VWF:RCo activity, VWF Collagen Binding (VWF:CB), RIPA, VWF propeptide (VWF:pp), multimeric analysis of VWF and the response of FVIII:C and VWF parameters to DDAVP. We here translate the ISTH into European, Clinical, Laboratory and Molecular (2020 ECLM) classification of the Von Willebrand Disease (VWD) related to the domain location of the Molecular (M) efect in the VWF gene to detect all variants of VWD. ER -
SMEJKAL, Petr, J. J. MICHIELS, Ondřej ZAPLETAL, Jan BLATNÝ, A. BATOROVA, T. PRICANGOVA, U. BUDDE, C. HERMANS, K. MAYGER, G. MOORE, I. VANGENEGTEN a Miroslav PENKA. European Clinical, Laboratory and Molecular (2020 ECLM) Diagnostic Work-Up and Classification of Von Willebrand Disease from the Perspectives of Clinicians and Scientists. \textit{Thrombosis \&{} Haemostasis: Research}. Austin Publishing, 2019, roč.~3, č.~3, s.~1-15. ISSN~2689-9663.
|